Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
This research aims to compare ARIMA and GRNN models alone. For this comparison the death rate for diabetes mellitus time series data of Canada is used. Autoregressive Integrated Moving Average (ARIMA), and Generalized Regression Neural Networks (GRNN) models were applied for time series prediction of the death rate for diabetes mellitus—trained data for two models from 2000 to 2015. Test data was used to compare the precision through data from 2016 to 2021. The ARIMA model was applied using the auto-command through R package which provided the least BIC and AIC values. The mean absolute deviation (MAD), root mean squared error (RMSE), and mean absolute percentage error (MAPE) were employed to measure the forecasting efficiency of the models. The ARIMA model had the highest prediction accuracy as compared to the GRNN model. ARIMA predicts the death rate for diabetes mellitus more accurately and robustly compared to the GRNNs model.
This research aims to compare ARIMA and GRNN models alone. For this comparison the death rate for diabetes mellitus time series data of Canada is used. Autoregressive Integrated Moving Average (ARIMA), and Generalized Regression Neural Networks (GRNN) models were applied for time series prediction of the death rate for diabetes mellitus—trained data for two models from 2000 to 2015. Test data was used to compare the precision through data from 2016 to 2021. The ARIMA model was applied using the auto-command through R package which provided the least BIC and AIC values. The mean absolute deviation (MAD), root mean squared error (RMSE), and mean absolute percentage error (MAPE) were employed to measure the forecasting efficiency of the models. The ARIMA model had the highest prediction accuracy as compared to the GRNN model. ARIMA predicts the death rate for diabetes mellitus more accurately and robustly compared to the GRNNs model.
BACKGROUND: Machine learning offers diverse options for effectively managing blood glucose levels in diabetes patients. Selecting the right ML algorithm is critical given the array of available choices. Integrating data from IoT devices presents promising opportunities to enhance real-time blood glucose management models. OBJECTIVE: This meta-analysis aims to evaluate the effectiveness of machine learning models utilizing IoT device data for predicting blood glucose levels. METHODS: We systematically searched electronic databases for studies published between 2019 and 2023. We excluded studies lacking ML model derivation or performance metrics. The Quality Assessment of Diagnostic Accuracy Studies tool assessed study quality. Our primary outcomes compared ML models for BG level prediction across different prediction horizons (PHs). RESULTS: We analyzed ten eligible studies across prediction horizons of 15, 30, 45, and 60 minutes. ML models exhibited mean absolute RMSE values of 15.02 (SD 1.45), 21.488 (SD 2.92), 30.094 (SD 3.245), and 35.89 (SD 6.4) mg/dL, respectively. Random Forest demonstrated superior performance across these PHs. CONCLUSION: We observed significant heterogeneity across all subgroups, indicating diverse sources of variability. As the PH lengthened, the RMSE for blood glucose prediction by the ML model increased, with Random Forest showing the highest relative performance among the ML models.
In recent years, the Internet of medical things (IoMT) has become a significant technological advancement in the healthcare sector. This systematic review aims to identify and summarize the various applications, key challenges, and proposed technical solutions within this domain, based on a comprehensive analysis of the existing literature. This review highlights diverse applications of the IoMT, including mobile health (mHealth) applications, remote biomarker detection, hybrid RFID-IoT solutions for scrub distribution in operating rooms, IoT-based disease prediction using machine learning, and the efficient sharing of personal health records through searchable symmetric encryption, blockchain, and IPFS. Other notable applications include remote healthcare management systems, non-invasive real-time blood glucose measurement devices, distributed ledger technology (DLT) platforms, ultra-wideband (UWB) radar systems, IoT-based pulse oximeters, accident and emergency informatics (A&EI), and integrated wearable smart patches. The key challenges identified include privacy protection, sustainable power sources, sensor intelligence, human adaptation to sensors, data speed, device reliability, and storage efficiency. The proposed mitigations encompass network control, cryptography, edge-fog computing, and blockchain, alongside rigorous risk planning. The review also identifies trends and advancements in the IoMT architecture, remote monitoring innovations, the integration of machine learning and AI, and enhanced security measures. This review makes several novel contributions compared to the existing literature, including (1) a comprehensive categorization of IoMT applications, extending beyond the traditional use cases to include emerging technologies such as UWB radar systems and DLT platforms; (2) an in-depth analysis of the integration of machine learning and AI in IoMT, highlighting innovative approaches in disease prediction and remote monitoring; (3) a detailed examination of privacy and security measures, proposing advanced cryptographic solutions and blockchain implementations to enhance data protection; and (4) the identification of future research directions, providing a roadmap for addressing current limitations and advancing the scientific understanding of IoMT in healthcare. By addressing current limitations and suggesting future research directions, this work aims to advance scientific understanding of the IoMT in healthcare.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.